Management of Osteoporosis Among Home Health and Long-Term Care Patients with a Prior Fracture

Osteoporosis is a growing health concern as the number of senior adults continues to increase worldwide. Falls and fractures are very common among frail older adults requiring home health and long-term care. Preventative strategies for reducing falls have been identified and many therapies (both prescription and nonprescription) with proven efficacy for reducing fracture risk are available. However, many practitioners overlook the fact that a fragility fracture is diagnostic for osteoporosis even without knowledge of bone mineral density testing. As a result, osteoporosis is infrequently diagnosed and treated in the elderly after a fracture. Based on existing literature, we have developed an algorithm for the assessment and treatment of osteoporosis among persons with known prior fracture(s) living in long-term care facilities or receiving home health care based on the data available in the literature.

[1]  J. Aloia,et al.  Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. , 2008, The American journal of clinical nutrition.

[2]  S. Cummings,et al.  Use of alendronate and risk of incident atrial fibrillation in women. , 2008, Archives of internal medicine.

[3]  N. Binkley,et al.  Rapid correction of low vitamin D status in nursing home residents , 2008, Osteoporosis International.

[4]  A. C. Laing,et al.  Effect of soft shell hip protectors on pressure distribution to the hip during sideways falls , 2008, Osteoporosis International.

[5]  Paul Stolee,et al.  Factors associated with a second hip fracture: a systematic review , 2008, Clinical rehabilitation.

[6]  M. Holick,et al.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.

[7]  L. Melton,et al.  Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA , 2008, Osteoporosis International.

[8]  O. Johnell,et al.  FRAX™ and the assessment of fracture probability in men and women from the UK , 2008, Osteoporosis International.

[9]  S. Boonen,et al.  Zoledronic acid and clinical fractures and mortality after hip fracture. , 2007, The New England journal of medicine.

[10]  Douglas P Kiel,et al.  Second hip fracture in older men and women: the Framingham Study. , 2007, Archives of internal medicine.

[11]  Rollin M. Wright.  Use of osteoporosis medications in older nursing facility residents. , 2007, Journal of the American Medical Directors Association.

[12]  H. Kamel.  Update on osteoporosis management in long-term care: focus on bisphosphonates. , 2007, Journal of the American Medical Directors Association.

[13]  Alan Bensoussan,et al.  Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis , 2007, The Lancet.

[14]  Simha Kimyagarov,et al.  [Frequency and reasons for falling among residents of the geriatric center]. , 2007, Harefuah.

[15]  D. Kiel,et al.  Efficacy of a Hip Protector to Prevent Hip Fracture in Nursing Home Residents The HIP PRO Randomized Controlled Trial , 2007 .

[16]  S. Cummings,et al.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. , 2007, The New England journal of medicine.

[17]  P. Miller.  Is There a Role for Bisphosphonates in Chronic Kidney Disease? , 2007, Seminars in dialysis.

[18]  A. Tosteson,et al.  Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  O. Johnell,et al.  Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial , 2007, Osteoporosis International.

[20]  K. Saag,et al.  Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture , 2007, Osteoporosis International.

[21]  D. Kiel,et al.  A Higher Dose of Vitamin D Reduces the Risk of Falls in Nursing Home Residents: A Randomized, Multiple‐Dose Study , 2007, Journal of the American Geriatrics Society.

[22]  J. Eisman,et al.  Risk of subsequent fracture after low-trauma fracture in men and women. , 2007, JAMA.

[23]  K. Kita,et al.  A simple protocol for preventing falls and fractures in elderly individuals with musculoskeletal disease , 2007, Osteoporosis International.

[24]  M. Rubin,et al.  The use of parathyroid hormone in the treatment of osteoporosis , 2007, Reviews in Endocrine and Metabolic Disorders.

[25]  Hao Wang,et al.  Impact of zoledronic acid on renal function in patients with cancer: Clinical significance and development of a predictive model. , 2006, The journal of supportive oncology.

[26]  M. Visser,et al.  Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. , 2006, The American journal of clinical nutrition.

[27]  K. Michaud,et al.  The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. , 2006, Archives of internal medicine.

[28]  A. Cranney,et al.  Evaluation of in-hospital management of fracture risk in older patients: a chart review study of tertiary prevention. , 2006, Archives of gerontology and geriatrics.

[29]  O. Johnell,et al.  The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective , 2006, Osteoporosis International.

[30]  Lee R. Mobley,et al.  Cost-Effectiveness of Osteoporosis Screening and Treatment with Hormone Replacement Therapy, Raloxifene, or Alendronate , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[32]  S. Boonen,et al.  Safety and Efficacy of Risedronate in Patients With Age‐Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical Trials , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  E. Warburton,et al.  Risedronate therapy for prevention of hip fracture after stroke in elderly women , 2005, Neurology.

[34]  G. Dalsky,et al.  Sustained Nonvertebral Fragility Fracture Risk Reduction After Discontinuation of Teriparatide Treatment , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  J. Iwamoto,et al.  Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. , 2005, Archives of internal medicine.

[36]  E. Ellerbeck,et al.  Differing Patterns of Antiresorptive Pharmacotherapy in Nursing Facility Residents and Community Dwellers , 2005, Journal of the American Geriatrics Society.

[37]  M. Holick,et al.  Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[38]  Bess Dawson-Hughes,et al.  Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[39]  I. Reid,et al.  Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. , 2005, The Journal of clinical endocrinology and metabolism.

[40]  J. Zerwekh,et al.  Severely suppressed bone turnover: a potential complication of alendronate therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[41]  D. Mellström,et al.  Osteoporosis in a nursing home, determined by the DEXA technique. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[42]  M. Maddens,et al.  Low bone mass and postfall fracture risk among elderly nursing home men. , 2004, Journal of the American Medical Directors Association.

[43]  B. Hollis,et al.  Vitamin D2 is much less effective than vitamin D3 in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[44]  J. Reginster,et al.  Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis. , 2004, Archives of internal medicine.

[45]  O Johnell,et al.  A meta-analysis of previous fracture and subsequent fracture risk. , 2004, Bone.

[46]  C. Christiansen,et al.  Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  B. Ettinger,et al.  Differential Effects of Teriparatide on BMD After Treatment With Raloxifene or Alendronate , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  C. Christiansen,et al.  Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study , 2004, Osteoporosis International.

[49]  L. Mosekilde,et al.  Vitamin D and Calcium Supplementation Prevents Osteoporotic Fractures in Elderly Community Dwelling Residents: A Pragmatic Population‐Based 3‐Year Intervention Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  J. Hopper,et al.  Serum Vitamin D and Falls in Older Women in Residential Care in Australia , 2003, Journal of the American Geriatrics Society.

[51]  J. Finkelstein,et al.  The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. , 2003, The New England journal of medicine.

[52]  Mary L Bouxsein,et al.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. , 2003, The New England journal of medicine.

[53]  J. Stakkestad,et al.  Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women , 2003, Annals of the rheumatic diseases.

[54]  C. Deal,et al.  Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis. , 2003, Cleveland Clinic journal of medicine.

[55]  R. Doll,et al.  Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.

[56]  R. Lew,et al.  Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  C Ronald MacKenzie,et al.  Hip fractures among the elderly: causes, consequences and control , 2003, Ageing Research Reviews.

[58]  P. Kulkarni,et al.  A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. , 2002, The Journal of clinical endocrinology and metabolism.

[59]  K. Lapane,et al.  Undertreatment of osteoporosis in residents of nursing homes: population-based study with use of the Systematic Assessment of Geriatric Drug Use via Epidemiology (SAGE) database. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[60]  G. Guyatt,et al.  VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women , 2002 .

[61]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[62]  M. Nowalk,et al.  A Randomized Trial of Exercise Programs Among Older Individuals Living in Two Long‐Term Care Facilities: The FallsFREE Program , 2001, Journal of the American Geriatrics Society.

[63]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[64]  P Geusens,et al.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. , 2001, The New England journal of medicine.

[65]  P. Klentrou,et al.  Longitudinal evaluation of supervised versus unsupervised exercise programs for the treatment of osteoporosis , 2000, European Journal of Applied Physiology.

[66]  D. Kiel,et al.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. , 2000, The American journal of medicine.

[67]  J. Chandler,et al.  Low bone mineral density and risk of fracture in white female nursing home residents. , 2000, JAMA.

[68]  T. Abbott,et al.  Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  I. Donald,et al.  Preventing falls on an elderly care rehabilitation ward , 2000, Clinical rehabilitation.

[70]  J A Stevens,et al.  Reducing falls and resulting hip fractures among older women. , 2000, Home care provider.

[71]  C C Glüer,et al.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. , 1999, JAMA.

[72]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[73]  D. Bauer,et al.  Physical Activity and Osteoporotic Fracture Risk in Older Women , 1998, Annals of Internal Medicine.

[74]  R. Lindsay,et al.  Alendronate Does Not Block the Anabolic Effect of PTH in Postmenopausal Osteoporotic Women , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[75]  W C Hayes,et al.  Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. , 1998, The American journal of medicine.

[76]  D. Kiel,et al.  Identifying Nursing Home Residents at Risk for Falling , 1998, Journal of the American Geriatrics Society.

[77]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[78]  T. M. Kashner,et al.  The Economic Cost of Hip Fractures in Community‐Dwelling Older Adults: A Prospective Study , 1997, Journal of the American Geriatrics Society.

[79]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[80]  W. Evans,et al.  Effects of exercise on body composition and functional capacity of the elderly. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[81]  M. Tinetti,et al.  The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. , 1995, JAMA.

[82]  S B Roberts,et al.  Exercise training and nutritional supplementation for physical frailty in very elderly people. , 1994, The New England journal of medicine.

[83]  C. Mulrow,et al.  A randomized trial of physical rehabilitation for very frail nursing home residents. , 1994, JAMA.

[84]  F Duboeuf,et al.  Vitamin D3 and calcium to prevent hip fractures in elderly women. , 1992, The New England journal of medicine.

[85]  E. Harju,et al.  Annual injection of vitamin D and fractures of aged bones , 1992, Calcified Tissue International.

[86]  Claus Christiansen,et al.  Diagnosis of Osteoporosis , 1992, Southern medical journal.

[87]  B. Riggs,et al.  Hip fracture recurrence. A population-based study. , 1982, Clinical orthopaedics and related research.

[88]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[89]  J. Gertner,et al.  25-Hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol. , 1977, Journal of clinical pathology.

[90]  L. Gillespie,et al.  Hip protectors for preventing hip fractures in older people. , 2010, The Cochrane database of systematic reviews.

[91]  P. Tugwell,et al.  Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. , 2008, The Cochrane database of systematic reviews.

[92]  P. Tugwell,et al.  Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. , 2008, The Cochrane database of systematic reviews.

[93]  Hideyo Yoshida,et al.  Randomized controlled trial of exercise intervention for the prevention of falls in community-dwelling elderly Japanese women , 2004, Journal of Bone and Mineral Metabolism.

[94]  R. Harwood,et al.  A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. , 2004, Age and ageing.

[95]  G. Guyatt,et al.  Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. , 2002, Endocrine reviews.

[96]  A. Avenell,et al.  Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. , 2000, The Cochrane database of systematic reviews.

[97]  J. Chandler,et al.  The Prevalence of Osteoporosis in Nursing Home Residents , 1999, Osteoporosis International.

[98]  J. Cauley,et al.  Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. , 1998, Annals of internal medicine.

[99]  P. Galan,et al.  Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.